Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

87 filings reported holding CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.3M shares of 58.8M outstanding shares and own 54.81% of the company stock.
Largest 10 shareholders include MPM Oncology Impact Management LP (7.91M shares), Foresite Capital Management V, LLC (2.73M shares), CHI Advisors LLC (2.24M shares), FMR LLC (1.98M shares), BAUPOST GROUP LLC/MA (1.84M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.44M shares), AMERICAN INTERNATIONAL GROUP, INC. (1.23M shares), VANGUARD GROUP INC (1.16M shares), ORBIMED ADVISORS LLC (1.15M shares), and Rock Springs Capital Management LP (1.08M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.